Corporate Sponsor Events
Roundtable - Vapotherm: Monday, April 29, 5:00 pm – 6:15 pm │ Location: Park West Ballroom Foyer
Hosts: John Walsh, Area Vice President of Clinical; Lise Halpern, Vice President of Marketing; George Dungan, Vice President of Science and Innovation
Take a Breath for EMF. Help Raise Money for the Emergency Medicine Foundation
John Walsh, Vapotherm Vice President of Clinical, will answer your questions on the current clinical practice of High-Velocity Nasal Insufflation (HVNI), a mask-free form of NIV for spontaneously breathing patients, in the Emergency Department. John began as Field Clinical Educator with Vapotherm in 2001. He was one of the early adopters of HVNI. He is the author of the first case study of its use in the Emergency Department and has 17 years of experience of helping hospitals implement the therapy.John will have a Vapotherm Precision Flow unit at the roundtable.
If you try on the Precision Flow unit, Vapotherm will donate $10 to the Emergency Medicine Foundation.
Roundtable - Portola Pharmaceuticals: Tuesday, April 30, 4:45 pm – 6:15 pm │ Location: Hunters Lounge
Hosts: Mufi Bootwala, Director Marketing; Stefan Stanko, Regional Business Director; Eva Solis, Thrombosis Area Manager
Portola Pharmaceuticals develops products in the fields of thrombosis and other hematologic diseases. Approved in the US: AndexXa® (andexanet alfa), a recombinant protein to reverse the anticoagulant effects of oral or injectable Factor Xa inhibitors.
Roundtable - Broselow Communications: Tuesday, April 30, 4:45 pm – 6:15 pm │ Location: Hunters Lounge
Hosts: James Broselow, MD, President; Robin Shannon, Vice President
Improving Patient Safety in a Snap!
Join Dr. Broselow for an interactive demonstration of his newest innovations in patient safety. See how just-in-time technologies can enhance healthcare communication, enable education, and safeguard transitions of care.
Complimentary Presentation Dinner - Portola Pharmaceuticals: Tuesday, April 30, 6:15 pm – 7:45 pm │ Location: Park West A
Title: Reversal of Specific Direct Oral Anticoagulants in Patients Experiencing Life-Threatening Bleeds: Review of Clinical Evidence and Practical Recommendations for Patient Management
Presenter: Colin G. Kaide, MD, FACEP, FAAEM, UHM, Professor, Emergency Medicine, The Ohio State University Wexner Medical Center; Emergency Physician, Premier Health Partners, Chief Clinical Advisor
Complimentary Presentation Dinner - Vapotherm: Wednesday, May 1, 6:45 pm – 8:15 pm │ Location: Park West F
Mask-Free NIV for Spontaneously Breathing Patients
Dr. Rebecca Reamy, Medical Director, Pediatric Emergency Department & Chief of Pediatrics, Piedmont Columbus Regional, will review the mechanisms of action, the clinical evidence and Emergency Department applications of High-Velocity Nasal Insufflation (HVNI), a mask-free form of noninvasive ventilation solution for patients in undifferentiated respiratory distress. Dr. Reamy will expand on Dr. Hinkley’s February EDDA presentation by providing an overview to a recent publication in the American Journal of Emergency Medicine, comparing HVNI to NiPPV in patients with decompensated heart failure. She also will speak to her experience using the therapy in Pediatrics.
Presenter: Rebecca Reamy, MD, FAAP, Medical Director, Pediatric Emergency Department and Chief of Pediatrics, Piedmont Columbus Regional
Complimentary Presentation Dinner - Persistent Systems: Thursday, May 2, 6:30 pm – 8:00 pm │ Location: Park West F
A Case Study of an Emergency Department Workflow Transformation using a Novel Technology Product
- Transform their growing healthcare data overload into actionable insights
- Allow front line caregivers to create and automate new workflows on the fly
- Leverage existing data with a novel technology tool that won 1st place winner HHS User Experience Challenge
- Embrace and utilize existing IT architecture and investments
Presenter: Bradford Diephuis, MD, Associate Vice President, Healthcare Growth and Solutions
I enjoyed the intensive experience and the camaraderie gained through interaction with other medical director/assistants.